HEADER OXIDOREDUCTASE 14-MAR-05 1Z3N
TITLE HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR
TITLE 2 LIDORESTAT AT 1.04 ANGSTROM
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: ALDOSE REDUCTASE;
COMPND 3 CHAIN: A;
COMPND 4 EC: 1.1.1.21;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21DE3;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B
KEYWDS OXIDOREDUCTASE, NADP+, LIDORESTAT
EXPDTA X-RAY DIFFRACTION
AUTHOR M.C.VAN ZANDT,M.L.JONES,D.E.GUNN,L.S.GERACI,J.H.JONES,D.R.SAWICKI,
AUTHOR 2 J.SREDY,J.L.JACOT,A.T.DICIOCCIO,T.PETROVA,A.MITSCHLER,A.D.PODJARNY
REVDAT 3 13-MAR-24 1Z3N 1 REMARK SEQADV
REVDAT 2 24-FEB-09 1Z3N 1 VERSN
REVDAT 1 14-MAR-06 1Z3N 0
JRNL AUTH M.C.VAN ZANDT,M.L.JONES,D.E.GUNN,L.S.GERACI,J.H.JONES,
JRNL AUTH 2 D.R.SAWICKI,J.SREDY,J.L.JACOT,A.T.DICIOCCIO,T.PETROVA,
JRNL AUTH 3 A.MITSCHLER,A.D.PODJARNY
JRNL TITL DISCOVERY OF
JRNL TITL 2 3-[(4,5,7-TRIFLUOROBENZOTHIAZOL-2-YL)METHYL]INDOLE-N-ACETIC
JRNL TITL 3 ACID (LIDORESTAT) AND CONGENERS AS HIGHLY POTENT AND
JRNL TITL 4 SELECTIVE INHIBITORS OF ALDOSE REDUCTASE FOR TREATMENT OF
JRNL TITL 5 CHRONIC DIABETIC COMPLICATIONS
JRNL REF J.MED.CHEM. V. 48 3141 2005
JRNL REFN ISSN 0022-2623
JRNL PMID 15857120
JRNL DOI 10.1021/JM0492094
REMARK 2
REMARK 2 RESOLUTION. 1.04 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : SHELXL-97
REMARK 3 AUTHORS : G.M.SHELDRICK
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.04
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 87.3
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF).
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.098
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.097
REMARK 3 FREE R VALUE (NO CUTOFF) : 0.125
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 6975
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 132616
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).
REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.090
REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL
REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.118
REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 6201
REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 117067
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2525
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 74
REMARK 3 SOLVENT ATOMS : 397
REMARK 3
REMARK 3 MODEL REFINEMENT.
REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2963.8
REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00
REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 107
REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 31049
REMARK 3 NUMBER OF RESTRAINTS : 43650
REMARK 3
REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.
REMARK 3 BOND LENGTHS (A) : 0.017
REMARK 3 ANGLE DISTANCES (A) : 0.032
REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000
REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029
REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.112
REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.105
REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.031
REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.006
REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.050
REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.122
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED: NULL
REMARK 3
REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER
REMARK 3 SPECIAL CASE: NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1Z3N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-MAR-05.
REMARK 100 THE DEPOSITION ID IS D_1000032256.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 22-SEP-98
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : LURE
REMARK 200 BEAMLINE : DW32
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.95
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 139636
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.040
REMARK 200 RESOLUTION RANGE LOW (A) : 15.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 87.2
REMARK 200 DATA REDUNDANCY : 2.700
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.04000
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.4000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.04
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.06
REMARK 200 COMPLETENESS FOR SHELL (%) : 85.4
REMARK 200 DATA REDUNDANCY IN SHELL : 2.10
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.25200
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.050
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 44.86
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: ALDOSE REDUCTASE, LIDORESTAT, NADP+,
REMARK 280 PEG 6000, PH 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.67000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -3
REMARK 465 SER A -2
REMARK 465 HIS A -1
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 MET A 0 CG - SD - CE ANGL. DEV. = 13.0 DEGREES
REMARK 500 ARG A 3 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES
REMARK 500 ARG A 3 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES
REMARK 500 ARG A 3 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES
REMARK 500 ARG A 40 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES
REMARK 500 ARG A 63 CG - CD - NE ANGL. DEV. = 13.9 DEGREES
REMARK 500 ARG A 63 CD - NE - CZ ANGL. DEV. = 8.6 DEGREES
REMARK 500 ARG A 63 CD - NE - CZ ANGL. DEV. = 13.1 DEGREES
REMARK 500 ARG A 63 NE - CZ - NH2 ANGL. DEV. = -4.5 DEGREES
REMARK 500 ASP A 149 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES
REMARK 500 TYR A 198 CB - CG - CD1 ANGL. DEV. = 5.5 DEGREES
REMARK 500 ARG A 217 NE - CZ - NH2 ANGL. DEV. = 4.5 DEGREES
REMARK 500 CYS A 298 CA - CB - SG ANGL. DEV. = -11.5 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 65 32.16 73.30
REMARK 500 ALA A 299 109.29 -164.60
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY
REMARK 500
REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY
REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER
REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 500 I=INSERTION CODE).
REMARK 500
REMARK 500 M RES CSSEQI ANGLE
REMARK 500 ARG A 40 -12.78
REMARK 500 ARG A 40 15.74
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 318
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3NA A 320
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1US0 RELATED DB: PDB
DBREF 1Z3N A 0 315 GB 178489 AAA51714 1 316
SEQADV 1Z3N GLY A -3 GB 178489 EXPRESSION TAG
SEQADV 1Z3N SER A -2 GB 178489 EXPRESSION TAG
SEQADV 1Z3N HIS A -1 GB 178489 EXPRESSION TAG
SEQRES 1 A 319 GLY SER HIS MET ALA SER ARG ILE LEU LEU ASN ASN GLY
SEQRES 2 A 319 ALA LYS MET PRO ILE LEU GLY LEU GLY THR TRP LYS SER
SEQRES 3 A 319 PRO PRO GLY GLN VAL THR GLU ALA VAL LYS VAL ALA ILE
SEQRES 4 A 319 ASP VAL GLY TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR
SEQRES 5 A 319 GLN ASN GLU ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS
SEQRES 6 A 319 LEU ARG GLU GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE
SEQRES 7 A 319 VAL SER LYS LEU TRP CYS THR TYR HIS GLU LYS GLY LEU
SEQRES 8 A 319 VAL LYS GLY ALA CYS GLN LYS THR LEU SER ASP LEU LYS
SEQRES 9 A 319 LEU ASP TYR LEU ASP LEU TYR LEU ILE HIS TRP PRO THR
SEQRES 10 A 319 GLY PHE LYS PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU
SEQRES 11 A 319 SER GLY ASN VAL VAL PRO SER ASP THR ASN ILE LEU ASP
SEQRES 12 A 319 THR TRP ALA ALA MET GLU GLU LEU VAL ASP GLU GLY LEU
SEQRES 13 A 319 VAL LYS ALA ILE GLY ILE SER ASN PHE ASN HIS LEU GLN
SEQRES 14 A 319 VAL GLU MET ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS
SEQRES 15 A 319 PRO ALA VAL ASN GLN ILE GLU CYS HIS PRO TYR LEU THR
SEQRES 16 A 319 GLN GLU LYS LEU ILE GLN TYR CYS GLN SER LYS GLY ILE
SEQRES 17 A 319 VAL VAL THR ALA TYR SER PRO LEU GLY SER PRO ASP ARG
SEQRES 18 A 319 PRO TRP ALA LYS PRO GLU ASP PRO SER LEU LEU GLU ASP
SEQRES 19 A 319 PRO ARG ILE LYS ALA ILE ALA ALA LYS HIS ASN LYS THR
SEQRES 20 A 319 THR ALA GLN VAL LEU ILE ARG PHE PRO MET GLN ARG ASN
SEQRES 21 A 319 LEU VAL VAL ILE PRO LYS SER VAL THR PRO GLU ARG ILE
SEQRES 22 A 319 ALA GLU ASN PHE LYS VAL PHE ASP PHE GLU LEU SER SER
SEQRES 23 A 319 GLN ASP MET THR THR LEU LEU SER TYR ASN ARG ASN TRP
SEQRES 24 A 319 ARG VAL CYS ALA LEU LEU SER CYS THR SER HIS LYS ASP
SEQRES 25 A 319 TYR PRO PHE HIS GLU GLU PHE
HET NDP A 318 48
HET 3NA A 320 26
HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE
HETNAM 2 NDP PHOSPHATE
HETNAM 3NA {3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-
HETNAM 2 3NA INDOL-1-YL}ACETIC ACID
HETSYN 3NA 3-[(4,5,7-TRIFLUOROBENZOTHIAZOL-2-YL)METHYL]INDOLE-N-
HETSYN 2 3NA ACETIC ACID
FORMUL 2 NDP C21 H30 N7 O17 P3
FORMUL 3 3NA C18 H11 F3 N2 O2 S
FORMUL 4 HOH *397(H2 O)
HELIX 1 1 PRO A 23 GLY A 38 1 16
HELIX 2 2 ALA A 45 GLN A 49 5 5
HELIX 3 3 ASN A 50 GLU A 64 1 15
HELIX 4 4 LYS A 68 LEU A 72 5 5
HELIX 5 5 TRP A 79 HIS A 83 5 5
HELIX 6 6 GLU A 84 GLY A 86 5 3
HELIX 7 7 LEU A 87 LYS A 100 1 14
HELIX 8 8 ASN A 136 GLU A 150 1 15
HELIX 9 9 ASN A 162 ASN A 171 1 10
HELIX 10 10 GLN A 192 LYS A 202 1 11
HELIX 11 11 SER A 226 GLU A 229 5 4
HELIX 12 12 ASP A 230 ASN A 241 1 12
HELIX 13 13 THR A 243 GLN A 254 1 12
HELIX 14 14 THR A 265 LYS A 274 1 10
HELIX 15 15 SER A 281 SER A 290 1 10
HELIX 16 16 LEU A 300 THR A 304 5 5
SHEET 1 A 2 ARG A 3 LEU A 5 0
SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4
SHEET 1 B 8 GLY A 16 GLY A 18 0
SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17
SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42
SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78
SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N ILE A 109
SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158
SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184
SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208
SITE 1 AC1 36 GLY A 18 THR A 19 TRP A 20 LYS A 21
SITE 2 AC1 36 ASP A 43 TYR A 48 HIS A 110 TRP A 111
SITE 3 AC1 36 SER A 159 ASN A 160 GLN A 183 TYR A 209
SITE 4 AC1 36 SER A 210 PRO A 211 LEU A 212 GLY A 213
SITE 5 AC1 36 SER A 214 PRO A 215 ASP A 216 ALA A 245
SITE 6 AC1 36 ILE A 260 PRO A 261 LYS A 262 SER A 263
SITE 7 AC1 36 VAL A 264 THR A 265 ARG A 268 GLU A 271
SITE 8 AC1 36 ASN A 272 3NA A 320 HOH A2085 HOH A2147
SITE 9 AC1 36 HOH A2149 HOH A2167 HOH A2168 HOH A2169
SITE 1 AC2 16 TRP A 20 TYR A 48 TRP A 79 CYS A 80
SITE 2 AC2 16 HIS A 110 TRP A 111 THR A 113 PHE A 115
SITE 3 AC2 16 PHE A 122 TRP A 219 CYS A 298 ALA A 299
SITE 4 AC2 16 LEU A 300 CYS A 303 TYR A 309 NDP A 318
CRYST1 50.140 67.340 47.880 90.00 92.50 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019944 0.000000 0.000871 0.00000
SCALE2 0.000000 0.014850 0.000000 0.00000
SCALE3 0.000000 0.000000 0.020905 0.00000